🔎 Trials Near Me

Home › Kanser sa Bibig › Kentucky

Pag-aaral pangklinika para sa Kanser sa Bibig sa Kentucky

5 pag-aaral para sa Kanser sa Bibig ang naghahanap ng mga kalahok sa mga site sa Kentucky.

Mga Lungsod sa Kentucky

Opisyal na teksto ng pag-aaral (English)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
  • Commonwealth Cancer Center-Corbin, Corbin
  • CommonSpirit Saint Joseph Hospital - Lexington, Lexington
  • at 6 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT02734537

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

  • University of Kentucky/Markey Cancer Center, Lexington
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

  • Baptist Health Hardin, Elizabethtown
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06532279

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

  • University of Kentucky/Markey Cancer Center, Lexington
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07441681

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • Norton Cancer Institute, Louisville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT04198766

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.